Loading clinical trials...
Loading clinical trials...
This is a Phase II, multi-center, randomized, double-blind study comparing the safety and efficacy of two doses of BC-3781 versus vancomycin in patients with acute bacterial skin and skin structure in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nabriva Therapeutics AG
NCT06306014 · Clostridioides Difficile Infection, Recurrent Infection
NCT07183592 · Intensive Care (ICU), Central Venous Catheter Related Infections, and more
NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection
NCT07388173 · Respiratory Infections in Old Age
NCT05190978 · Breast Cancer, Breast Implant; Complications, Infection or Inflammation
BC-3781 Study Center 002
Chula Vista, California
BC-3781 Study Center 001
La Mesa, California
BC-3781 Study Center 003
Oceanside, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions